AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding AbCellera Biologics Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 114 | 116 | +2 |
| Shares | 90.6M | 98.7M | +8.14M (+9.0%) |
| Value | $1.99B | $1.98B | −$8.58M (−0.4%) |
New holders (28)
Institutions that held AbCellera Biologics Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (26)
Institutions that held AbCellera Biologics Inc. at the end of Q2 2021 and filed for Q3 2021 without it.